You have 9 free searches left this month | for more free features.

T-cell vaccine

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19 Trial in Johannesburg (AAHI-SC2 Vaccine, AAHI-SC3 Vaccine, EUA or approved vaccine)

Recruiting
  • COVID-19
  • AAHI-SC2 Vaccine
  • +2 more
  • Johannesburg, South Africa
    Wits Vida
Jan 4, 2023

HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

Recruiting
  • HER2-positive Breast Cancer
  • Dendritic Cell (DC1) Vaccine
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin

Not yet recruiting
  • High Grade B-Cell Non-Hodgkin's Lymphoma
  • +3 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2023

Idiopathic CD4 T Cell Lymphocytopenia Trial run by the NIAID (Gardasil 9)

Recruiting
  • Idiopathic CD4 T Cell Lymphocytopenia
  • Gardasil 9
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 10, 2023

Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

Not yet recruiting
  • Kidney Transplant
  • +2 more
  • Boston, Massachusetts
  • +2 more
Sep 20, 2023

Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Imus, Makati City (PepGNP-COVID19 (One vaccination), Water for injection

Not yet recruiting
  • Coronavirus
  • +2 more
  • PepGNP-COVID19 (One vaccination)
  • +3 more
  • Imus, Cavite, Philippines
  • +1 more
Nov 30, 2022

Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

Not yet recruiting
  • Refractory Leukemia
  • +4 more
  • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
  • Dendritic Cell Vaccine
  • Miami, Florida
    University of Miami
Jan 23, 2023

COVID Vaccine Immunity in Kidney Transplant Recipients

Withdrawn
  • End Stage Renal Disease
  • Kidney Transplant; Complications
  • Coronavirus (COVID-19) SARS-CoV-2 inSIGHTâ„¢ T Cell Immunity Test
  • (no location specified)
Oct 25, 2022

Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) Trial in

Recruiting
  • Diffuse Large-Cell Lymphoma
  • +3 more
  • Pneumococcal conjugate vaccine (PCV13)
  • CD19 targeted CAR T Cell Therapy
  • Tampa, Florida
    Moffitt Cancer Center
May 31, 2022

B-Cell Non-Hodgkin Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Duarte (Anti-CD19-CAR CMV-specific T-lymphocytes, Autologous

Not yet recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jun 28, 2022

Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)

Active, not recruiting
  • Plasma Cell Myeloma
  • Omaha, Nebraska
    University of Nebraska Medical Center
Nov 21, 2022

T-Cell Acute Lymphoblastic Leukemia Trial in Shenzhen (Antigen-specific T cells CAR-T/CTL and DCvac)

Recruiting
  • T-Cell Acute Lymphoblastic Leukemia
  • Antigen-specific T cells CAR-T/CTL and DCvac
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Mar 14, 2022

Non Small Cell Lung Cancer Trial in Leiden, Rotterdam (TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51))

Recruiting
  • Non Small Cell Lung Cancer
  • TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51)
  • Leiden, Zuid-Holland, Netherlands
  • +1 more
Jun 1, 2023

Flu Vaccine Trial in Nashville (Fluzone-High Dose Quadrivalent, Fluad, Flublock)

Completed
  • Flu Vaccine
  • Fluzone-High Dose Quadrivalent
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 16, 2022

Prostate Specific Antigens, Prostate Tumors Trial run by the National Cancer Institute (NCI) (TARP peptide vaccine, TARP

Completed
  • Prostate Specific Antigens
  • Prostate Neoplasms
  • T-cell receptor alternate reading frame protein (TARP) peptide vaccine
  • T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 15, 2022

Dengue Trial in Lausanne (LD vehicle-GNP, LD PepGNP-Dengue, HD vehicle-GNP)

Completed
  • Dengue
  • LD vehicle-GNP
  • +3 more
  • Lausanne, Vaud, Switzerland
    Center for Primary Care and Public Health, (Unisante)
Nov 28, 2022

FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at

Recruiting
  • Monkeypox
    • Antwerp, Belgium
      Institute of Tropical Medicine
    May 19, 2023

    Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

    Not yet recruiting
    • Epithelial Ovarian Cancer
    • Ovarian Carcinoma
    • XP-DC vaccinations
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Center
    Mar 6, 2023

    Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,

    Active, not recruiting
    • Aggressive Non-Hodgkin Lymphoma
    • +9 more
    • Cryosurgery
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 9, 2022

    Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Lausanne (LD Vehicle-GNP, LD PepGNP-SARSCoV2, HD Vehicle-GNP)

    Completed
    • Coronavirus
    • +2 more
    • LD Vehicle-GNP
    • +3 more
    • Lausanne, Vaud, Switzerland
      Center for Primary Care and Public Health (Unisante)
    Nov 28, 2022

    B-Cell Acute Lymphoblastic Leukemia Trial in Shenzhen (Antigen-specific T cells CART/CTL and DCvac)

    Recruiting
    • B-Cell Acute Lymphoblastic Leukemia
    • Antigen-specific T cells CART/CTL and DCvac
    • Shenzhen, Guangdong, China
      Shenzhen Geno-Immune Medical Institute
    Mar 7, 2022

    Covid19 Trial (hAd5-S-Fusion+N-ETSD vaccine)

    Withdrawn
    • Covid19
    • hAd5-S-Fusion+N-ETSD vaccine
    • (no location specified)
    Dec 14, 2021

    COVID-19, Infection Viral, Infections Trial in Bergen, Oslo (VB10.2129, VB10.2210)

    Active, not recruiting
    • COVID-19
    • +2 more
    • VB10.2129
    • VB10.2210
    • Bergen, Norway
    • +1 more
    Jan 6, 2023

    Covid19 Trial (hAd5-S-Fusion+N-ETSD vaccine)

    Withdrawn
    • Covid19
    • hAd5-S-Fusion+N-ETSD vaccine
    • (no location specified)
    Dec 14, 2021

    HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

    Not yet recruiting
    • HIV-1-infection
    • ChAdOx1.tHIVconsv1
    • +7 more
    • San Diego, California
    • +11 more
    Oct 4, 2023